Skip to main content
. 2018 Aug 13;13:2409–2423. doi: 10.2147/COPD.S152723

Figure 4.

Figure 4

Analysis of the proportion of patients who continued receiving their randomized treatment in (A) GOLD group A; (B) GOLD group B; (C) GOLD group C; (D) GOLD group D.

Note: Figures in parentheses represent 95% CIs.

Abbreviations: FP/SAL, fluticasone propionate/salmeterol; GOLD, Global initiative for chronic Obstructive Lung Disease 2011 criteria; TIO, tiotropium.